LEXINGTON, Mass., July 27,
2021 /PRNewswire/ -- iSpecimen
Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an
online marketplace for human biospecimens, today announced that it
will report its financial results for the second quarter ended
June 30, 2021, before the market open
on Tuesday, August 10, 2021.
The Company will host a conference call and audio webcast that
morning at 8:30 a.m. Eastern Time
featuring remarks by Christopher
Ianelli, MD, PhD, CEO and President, Tracy Curley, CFO, and Jill Mullan, COO.
Quarter 2021 Results Conference Call
Tuesday, August 10,
8:30 a.m. Eastern
Free) or + 1-201-389-0878 (International)
For interested individuals unable to join the conference call, a
replay will be available through August 24,
2021, at +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671
(International). Participants must use the following code to access
the replay of the call: 13721607. An archived version of the
webcast will also be available on iSpecimen's Investor Relations
iSpecimen offers an online marketplace
for human biospecimens, connecting life scientists in commercial
and non-profit organizations with healthcare providers that have
access to patients and specimens needed for medical discovery.
Proprietary, cloud-based technology enables scientists to
intuitively search for specimens and patients across a federated
partner network of hospitals, labs, biobanks, blood centers, and
other healthcare organizations. For more information about
iSpecimen, please visit www.ispecimen.com.
Forward Looking Statements
This press release may
contain forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended. Such
forward-looking statements are characterized by future or
conditional verbs such as "may," "will," "expect," "intend,"
"anticipate," believe," "estimate" and "continue" or similar words.
You should read statements that contain these words carefully
because they discuss future expectations and plans, which contain
projections of future results of operations or financial condition
or state other forward-looking information.
Forward-looking statements are predictions, projections and
other statements about future events that are based on current
expectations and assumptions and, as a result, are subject to risks
and uncertainties. Many factors could cause actual future events to
differ materially from the forward-looking statements in this press
release, including but not limited to the risks factors contained
in the Company's filings with the Securities and Exchange
Commission, which are available for review at www.sec.gov.
Forward-looking statements speak only as of the date they are made.
New risks and uncertainties arise over time, and it is not possible
for the Company to predict those events or how they may affect the
Company. If a change to the events and circumstances reflected in
the Company's forward-looking statements occurs, the Company's
business, financial condition and operating results may vary
materially from those expressed in the Company's forward-looking
Readers are cautioned not to put undue reliance on
forward-looking statements, and the Company assumes no obligation
and do not intend to update or revise these forward-looking
statements, whether as a result of new information, future events
For further information, please contact:
KCSA Strategic Communications
Allison Soss / Scott Eckstein
View original content to download
SOURCE iSpecimen Inc.